Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf PK in First Nations vs Caucasian Liver Transplant Patients
NCT04237246Phase 4Completed
- Sponsor
- University of Manitoba
- Start
- Apr 2015
- Primary completion
- Nov 2019
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus in Liver transplant rejection (2 cohorts), sponsored by University of Manitoba. Primary endpoints: Concentration at zero time at 24 hours, Time to maximum concentration at 24 hours and 3 more. Started Apr 2015; status: completed.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT04237246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04237246.